Mumme, Hope L. https://orcid.org/0000-0002-4171-1736
Huang, Chenbin https://orcid.org/0000-0002-2179-2217
Ohlstrom, Denis https://orcid.org/0000-0003-1920-6319
Bakhtiari, Mojtaba
Raikar, Sunil S. https://orcid.org/0000-0003-2903-9542
DeRyckere, Deborah https://orcid.org/0000-0002-7457-9006
Qayed, Muna
Castellino, Sharon M.
Wechsler, Daniel S.
Porter, Christopher C. https://orcid.org/0000-0001-8774-0180
Graham, Douglas K. https://orcid.org/0000-0002-6201-6900
Bhasin, Swati S. https://orcid.org/0000-0001-8661-1459
Bhasin, Manoj https://orcid.org/0000-0001-5172-420X
Funding for this research was provided by:
Emory Startup Funds
CURE Childhood Cancer
Article History
Received: 30 April 2024
Accepted: 21 April 2025
First Online: 2 May 2025
Competing interests
: MBh serves on the board of Canomiks Inc. as chief scientific advisor and has equity in it. DKG and DD hold equity in Meryx Inc. SSB serves as CEO of Anxomics LLC and has equity in it. The remaining authors declare no other competing interests.